Second assessment of NeuroAIDS in Africa

Item

http://www.wikidata.org/entity/Q37371300

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Second assessment of NeuroAIDS in Africa

@en

Second assessment of NeuroAIDS in Africa.

@nl

type

Item

label

Second assessment of NeuroAIDS in Africa

@en

Second assessment of NeuroAIDS in Africa.

@nl

prefLabel

Second assessment of NeuroAIDS in Africa

@en

Second assessment of NeuroAIDS in Africa.

@nl

P1476

Second assessment of NeuroAIDS in Africa

@en

P2093

Christina Marra

http://www.w3.org/2001/XMLSchema#string

Christine Zink

http://www.w3.org/2001/XMLSchema#string

Colin Hall

http://www.w3.org/2001/XMLSchema#string

Concepta Merry

http://www.w3.org/2001/XMLSchema#string

David Clifford

http://www.w3.org/2001/XMLSchema#string

Farida AMod

http://www.w3.org/2001/XMLSchema#string

James Hakim

http://www.w3.org/2001/XMLSchema#string

Janice Clements

http://www.w3.org/2001/XMLSchema#string

Jeff Liner

http://www.w3.org/2001/XMLSchema#string

Jens Mielk

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda

Human immunodeficiency virus type 1 subtypes differ in disease progression

Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea

HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the Manhattan HIV Brain Bank.

Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus.

Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts.

HIV-1/AIDS and maternal and child health in Africa.

Clinical implications of CNS penetration of antiretroviral drugs.

Changing patterns in the neuropathogenesis of HIV during the HAART era.

Clinical implications of HIV-1 drug resistance in the neurological compartment.

P2888

13550280701829793

P304

87-101

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13550280701829793

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5482883

http://www.w3.org/2001/XMLSchema#string

P6179

1024855022

http://www.w3.org/2001/XMLSchema#string

P698

18370346

http://www.w3.org/2001/XMLSchema#string

P921

AIDS

P932

2755561

http://www.w3.org/2001/XMLSchema#string